DENVER, Nov. 10, 2016 -- Cannabis and CBD innovator, Elixinol will be expanding its partnerships and announcing new product lines at the 2016 Marijuana Business Conference and Expo November 16-18 in Las Vegas. The 3-day business-to-business conference known also as the MJ Biz Conference, will include cannabis leaders, like Elixinol, from around the United States.
Elixinol is title sponsor of the The Mixer, an event where 100% of tickets sales will be donated to non-profits working at the national and federal level to reform cannabis laws, advocate patient access and reduce harms caused by the nation’s current drug enforcement approach.
“Because Elixinol CBD products don’t have the effects of THC, Elixinol CBD is already legal in all 50 states and available in 40 countries, but recent election results in 9 states including Nevada, increased access to cannabis,” said Chris Husong Director of Sales and Marketing for Elixinol.
“We support normalizing cannabis and increased access for patients around the world,” he continued.
Elixinol will be sharing cannabis and CBD insights with an estimated 7,500 industry leaders and will have 3 new product lines available including its topical product Rescue Balm and Respira, its newest tincture suitable for vaping.
“Because education is such an important part of our company culture, we wanted to be able to share the latest formulation and delivery CBD innovations with the cannabis industry,” says Husong.
The entire Elixinol product line will be at the conference. To schedule interviews and see the new product lines first-hand, please email Chris Husong for a private appointment or visit booth #748 on the tradeshow floor.
“The Marijuana Business Conference and Expo is a great closing to our best year yet which included several new product lines and expansion into new markets like Japan and the UK,” said Husong.
“We’ve been around the world this year and we’re very excited to add this conference to our plans and expect it will be a great experience for all involved,” he continued.
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD manufacturers with a proven track record of consulting, growing and manufacturing high quality hemp, laboratory testing and quality control. A global leader in distribution and cannabis education, Elixinol distributes CBD products in the United States, Japan, UK and Puerto Rico. Elixinol and its global partners, including Elixinol Japan, recently introduced World Hemp Conference Innovation winner hemp oil Liposomes, with superior absorption and real fruit flavor and the Xpen, the most precise CBD oil delivery system available. More information available at: elixinol.com
Media Contact: Chris Husong Elixinol 408-420-8890 (m) [email protected]


GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 



